Predictors of in vitro response to somatostatin and dopamine receptor-targeted treatments are lacking in clinically non-functioning pituitary tumors. [PDF]
J NeuroendocrinolCampana C +9 more
europepmc +1 more source
Relative Sertoli-cell FSH hyporesponsiveness as a potential contributor to sperm DNA fragmentation: a hypothesis-driven narrative review and proposal of the FERTILE framework. [PDF]
Front UrolKandil H.
europepmc +1 more source
Spatiotemporal modeling of GPCR signaling: The role of endosomal dynamics and receptor recycling. [PDF]
PLoS Comput BiolWeckel C +8 more
europepmc +1 more source
Rethinking gonadotropin releasing hormone agonist suppression test: why it should be a gonadotropin releasing hormone antagonist suppression test. [PDF]
J Endocr SocMunshi R, Coutu Nadeau LP, Dahan MH.
europepmc +1 more source
Urinary and Recombinant Follicle-Stimulating Hormone in Supporting Primate Follicular Development In Vitro. [PDF]
Curr Issues Mol BiolXu F, Ibrahim S, Xu J.
europepmc +1 more source
The extragonadal biology of gonadotropin hormones: should we rename these? [PDF]
Endocr ConnectKim SM +19 more
europepmc +1 more source
Glucagon-like receptor-1 agonists and impotence: A meta-analysis. [PDF]
World J MethodolMirghani HO, AlQurashi AM.
europepmc +1 more source
Determine the Role of FSH Receptor Binding Inhibitor in Regulating Ovarian Follicles Development and Expression of FSHR and ERα in Mice. [PDF]
Biomed Res Int, 2018 Lai L +5 more
europepmc +1 more source
Follicular development impairment in polyendocrine metabolic ovarian syndrome: multidimensional pathophysiological networks and frontier therapeutic targets. [PDF]
Front ImmunolJia Q +5 more
europepmc +1 more source